Using MRI for safer pelvic measurements in pregnant women
MRI Pseudo-CT Sequences for Obstetrical Pelvimetry
This study is testing a new MRI method to safely measure the pelvis in pregnant women without using radiation, to see if it works as well as traditional CT scans.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 95 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | Female |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT06485323 on ClinicalTrials.gov |
What this trial studies
This study evaluates the use of advanced MRI sequences to perform pelvimetry, which is a measurement of the pelvis, as a non-irradiating alternative to traditional CT pelvimetry. The focus is on new MRI techniques that provide optimal contrast between bone and soft tissue while significantly reducing acquisition time to under 10 minutes. The goal is to validate this rapid MRI approach to ensure it is as reliable as CT for assessing pelvic dimensions in pregnant women. This could lead to safer imaging practices for expectant mothers.
Who should consider this trial
Good fit: Ideal candidates are pregnant women between 33 to 41 weeks who have previously had a cesarean section and require pelvimetry for their next pregnancy.
Not a fit: Patients with contraindications to MRI, such as pacemakers or severe claustrophobia, will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could eliminate radiation exposure for pregnant women while providing accurate pelvic measurements.
How similar studies have performed: Preliminary tests have shown promise for similar MRI techniques, but this specific approach is novel and requires validation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant woman 33 to 41 week * Woman who gave birth by cesarean section, for whom the obstetrician requests a pelvimetry CT for the next pregnancy * Pelvimetry planned by the obstetrical team outside of "emergency" pathway * Adhere to the study protocol after reading the patient information document have signed the informed consent form to participate in the study Exclusion Criteria: * Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…) * Severe claustrophobia * uncomfortable back position
Where this trial is running
Brussels
- Cliniques Universaires Siant Luc — Brussels, Belgium (Recruiting)
Study contacts
- Principal investigator: Frédéric Lecouvet, MD, PhD — Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Study coordinator: Frédéric Lecouvet, MD, PhD
- Email: frederic.lecouvet@saintluc.uclouvain.be
- Phone: +3227642793
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.